Chemed Corp: Form 10-Q for the period ended Mar 31, 2017
Filed with the SEC on Apr 28, 2017 and accepted by EDGAR at Apr 28, 2017, 07:58 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2017-03-31. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2017-01-01 to 2017-03-31 | $405.9m | us-gaap:SalesRevenueNet |
| Cost of revenue | 3 months2017-01-01 to 2017-03-31 | $285.1m | us-gaap:CostOfGoodsAndServicesSold |
| Selling, general and administrative | 3 months2017-01-01 to 2017-03-31 | $69.5m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 3 months2017-01-01 to 2017-03-31 | $41.5m | us-gaap:OperatingIncomeLoss |
| Interest expense | 3 months2017-01-01 to 2017-03-31 | $995.0k | us-gaap:InterestExpense |
| Income tax | 3 months2017-01-01 to 2017-03-31 | $13.1m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2017-01-01 to 2017-03-31 | $29.8m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2017-01-01 to 2017-03-31 | $1.78 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months2017-01-01 to 2017-03-31 | $1.84 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months2017-01-01 to 2017-03-31 | 16,801,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Capital expenditure | 3 months2017-01-01 to 2017-03-31 | $9.0m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Dividends paid | 3 months2017-01-01 to 2017-03-31 | $4.3m | us-gaap:PaymentsOfDividendsCommonStock |
| Share repurchases | 3 months2017-01-01 to 2017-03-31 | $54.3m | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | At period end2017-03-31 | $47.0m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2017-03-31 | $176.0m | us-gaap:AssetsCurrent |
| Total assets | At period end2017-03-31 | $886.2m | us-gaap:Assets |
| Current liabilities | At period end2017-03-31 | $164.4m | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2017-03-31 | $385.6m | us-gaap:Liabilities |
| Long-term debt | At period end2017-03-31 | $137.5m | us-gaap:LongTermDebtNoncurrent |
| Current portion of debt | At period end2017-03-31 | $9.4m | us-gaap:LongTermDebtCurrent |
| Shareholders' equity | At period end2017-03-31 | $500.6m | us-gaap:StockholdersEquity |
| Shares outstanding | At period end2017-03-31 | 16,082,181 shares | dei:EntityCommonStockSharesOutstanding |
Source: SEC EDGAR, the filing index for accession 0001157523-17-001278. Last ingested by Listed: Oct 29, 2026, 09:14 ET. Listed shows no prices and gives no investment advice.